Fecal microbiota transplantation: What we know and what we need to know

Annals of Internal Medicine

Volumn 162, Issue 9, 2015, Pages 662-663

  Surawicz, Christina M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ENEMA; PROBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC THERAPY; BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COLONOSCOPY; COST BENEFIT ANALYSIS; COST CONTROL; CRITICALLY ILL PATIENT; EDITORIAL; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; HUMAN; ILEOSTOMY; PEPTOCLOSTRIDIUM DIFFICILE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RECURRENT DISEASE; REINFECTION; RISK BENEFIT ANALYSIS; UPPER GASTROINTESTINAL TRACT; CLOSTRIDIUM INFECTIONS; FECES; MICROBIOLOGY; MICROFLORA; PROCEDURES;

BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECES; HUMANS; MICROBIOTA;

EID: 84928880286     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-0609     Document Type: Editorial

References (10)

1. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407-15. [PMID: 23323867] doi:10.1056/NEJMoa1205037
2. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108:478-98. [PMID: 23439232] doi:10.1038/ajg.2013.4
3. Debast SB, Bauer MP, Kuijper EJ; European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20 Suppl 2:1-26. [PMID: 24118601] doi:10.1111/1469 -0691.12418
4. Drekonja D, Reich J, Gezahegn S, Greer N, Shaukat A, MacDonald R, et al. Fecal microbiota transplantation for Clostridium difficile infection. A systematic review. Ann Intern Med. 2015;162:630-8. doi: 10.7326/M14-2693
5. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and metaanalysis. Am J Gastroenterol. 2013;108:500-8. [PMID: 23511459] doi:10.1038/ajg.2013.59
6. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313: 398-408. [PMID: 25626036] doi:10.1001/jama.2014.17103
7. Cammarota G, Masucci L, Ianiro G, Bibbo S, Dinoi G, Costamagna G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015. [PMID: 25728808] doi:10.1111/apt.13144
8. Konijeti GG, Sauk J, Shrime MG, Gupta M, Ananthakrishnan AN. Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis. Clin Infect Dis. 2014;58:1507-14. [PMID: 24692533] doi:10.1093/cid/ciu128
9. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079-87. [PMID: 22450732] doi:10.1038/ajg.2012.60
10. Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis. 2008; 197:435-8. [PMID: 18199029] doi:10.1086/525047